Physician profile
Ruby Ann Eguez
NPI 1730537507
$1,021.99
in general payments reported to CMS, 2019-2025
19 companies · $64.26 in 2025
The $64.26 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $244 · 2022: $94.99 · 2023: $360 · 2024: $259 · 2025: $64.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.64 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $342.10 | 2021-2024 | |
| Amgen INC. | $153.02 | 2021-2024 | Otezla, Repatha |
| Novo Nordisk INC | $117.67 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $70.73 | 2023-2024 | Jardiance, Emgality |
| Bayer Healthcare Pharmaceuticals INC. | $48.81 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $28.80 | 2022 | |
| Amarin Pharma, INC. | $26.75 | 2021 | |
| Cmp Pharma, INC. | $25.67 | 2021 | |
| Currax Pharmaceuticals LLC | $25.00 | 2023 | Nexletol |
| Otsuka America Pharmaceutical, INC. | $23.87 | 2025 | Rexulti |
| Astellas Pharma US INC | $21.20 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.68 | 2025 | |
| Medtronic, INC. | $19.40 | 2024 | Minimed 780g |
| Janssen Pharmaceuticals, INC | $18.96 | 2024 | Xarelto |
| Merck Sharp & Dohme LLC | $18.12 | 2023 | Verquvo, Belsomra, Steglatro |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $18.11 | 2024 | Arexvy, Trelegy Ellipta |
| Pfizer INC. | $15.80 | 2022 | |
| Philips North America LLC | $14.46 | 2024 | (8874) Incourage |
| Kowa Pharmaceuticals America, INC. | $13.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ruby Ann Eguez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.